U-Chart Analysis:Astellas Pharma Inc.:4503

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Astellas Pharma Inc. Go to web site 4503 Medicals 1st TSE March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Astellas Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Balance Sheet 2020年3月期 Astellas Pharma Inc. Balance Sheet 2019年3月期 Astellas Pharma Inc. Balance Sheet 2018年3月期 Astellas Pharma Inc. Balance Sheet 2017年3月期 Astellas Pharma Inc. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents 318,391 311,074 331,731 340,923 360,030
Other Current AssetsHelp 549,123 546,085 513,888 535,742 537,507
Tangible Fixed AssetsHelp 268,600 173,483 181,295 191,115 200,955
Intangible Fixed AssetHelp 724,773 429,707 416,912 387,419 339,202
Investments and OthersHelp 176,029 211,435 201,403 190,352 210,984
Total AssetsHelp 2,315,169 1,897,648 1,858,205 1,814,072 1,799,338
Total Current LiabilitiesHelp 896,729 586,370 540,494 513,873 539,407
Total Long-term LiabilitiesHelp 129,272 52,882 49,422 28,389 722
Shareholder's EquityHelp 1,289,168 1,258,396 1,268,289 1,271,810 1,259,209
Total LiabilitiesHelp 2,315,169 1,897,648 1,858,205 1,814,072 1,799,338

Astellas Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Profit and Loss Account 2020年3月期 Astellas Pharma Inc. Profit and Loss Account 2019年3月期 Astellas Pharma Inc. Profit and Loss Account 2018年3月期 Astellas Pharma Inc. Profit and Loss Account 2017年3月期 Astellas Pharma Inc. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales 1,300,843 1,306,348 1,300,316 1,311,665 1,372,706
Total Sales 1,300,843 1,306,348 1,300,316 1,311,665 1,372,706
Cost of SalesHelp 276,739 292,050 294,250 320,503 335,596
Other Costs and RevenueHelp 828,693 792,033 841,387 772,462 843,423
Total CostsHelp 1,105,432 1,084,083 1,135,637 1,092,965 1,179,019
Net RevenueHelp 1,024,104 1,014,298 1,006,066 991,162 1,037,110
Earnings Before TaxHelp 245,350 248,967 218,113 281,769 261,770
Net IncomeHelp 195,411 222,265 164,679 218,700 193,687
Net Income 195,411 222,265 164,679 218,700 193,687

Astellas Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Cash Flow Statement 2020年3月期 Astellas Pharma Inc. Cash Flow Statement 2019年3月期 Astellas Pharma Inc. Cash Flow Statement 2018年3月期 Astellas Pharma Inc. Cash Flow Statement 2017年3月期 Astellas Pharma Inc. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help 221,997 256,899 312,615 235,612 313,736
Investing Cash Flow(ICF)Help -389,793 -41,757 -121,799 -73,383 -147,050
Financing Cash FlowHelp 181,055 -233,681 -203,429 -166,153 -193,478
Exchange Difference of Cash and Cash EquivalentsHelp -5,942 -2,118 3,421 -15,183 -9,609
Net Increase and Decrease in Cash and Cash Equivalentsn 7,317 -20,657 -9,192 -19,107 -36,401

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Astellas Pharma Inc.

Company where related level is highHelp

TAIKO PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
HEALIOS K.K.
TAISHO PHARMACEUTICAL CO.,LTD.
KISSEI PHARMACEUTICAL CO.,LTD.
NIPPON CHEMIPHAR CO.,LTD.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
RaQualia Pharma Inc.
TOWA PHARMACEUTICAL CO.,LTD.
Fuso Pharmaceutical Industries, Ltd.